Home › Brain Tumors › Michigan › Grand Rapids
Brain Tumors clinical trials in Grand Rapids, MI
4 studies for Brain Tumors are looking for participants at sites in and around Grand Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecruitingPhase 1/2
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RecruitingPhase 1
- START - Midwest Cancer Research Center, Grand Rapids
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecruitingPhase 3
- Spectrum Health at Butterworth Campus, Grand Rapids
About Brain Tumors
A brain tumor is a growth of abnormal cells in the brain tissue. Learn the types of tumors, symptoms, how they are diagnosed and treatment options.
More about Brain Tumors on MedlinePlus
Brain Tumors trials in other cities
- Houston, TX35 studies
- Boston, MA28 studies
- New York City, NY25 studies
- Washington, DC20 studies
- Los Angeles, CA16 studies
- Miami, FL15 studies
- Durham, NC14 studies
- St. Louis, MO12 studies
- Rochester, MN12 studies
- Columbus, OH11 studies
- Baltimore, MD11 studies
- Chicago, IL11 studies
Other studies in Grand Rapids
- Non-Small Cell Lung Cancer43 studies
- Colorectal Cancer40 studies
- Cancer (all types)29 studies
- Breast Cancer25 studies
- Ovarian Cancer24 studies
- Metastatic Cancer22 studies
- Endometrial Cancer19 studies
- Prostate Cancer19 studies
- Pancreatic Cancer18 studies
- Stomach Cancer18 studies
- Melanoma17 studies
- Triple-Negative Breast Cancer15 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.